|
Endonetics Inc
|
United States |
|
N/A
|
|
|
|
Esperion Therapeutics Inc
|
United States |
|
N/A
|
|
|
|
Excaliard Pharmaceuticals Inc
|
United States |
|
N/A
|
|
|
|
Eyetech Inc
|
United States |
|
N/A
|
|
|
|
Eyetech Pharmaceuticals Inc
Biopharmaceutical company that specializes in the development and commercialization of novel therapeutics to treat diseases of the eye. |
United States |
|
N/A
|
|
|
|
Fibex Systems Inc
|
United States |
|
N/A
|
|
|
|
Flamel Technologies SA
|
France |
|
N/A
|
|
|
|
FoldRx Pharmaceuticals Inc
|
United States |
|
N/A
|
|
|
|
Genedata AG
|
Switzerland |
|
N/A
|
|
|
|
Guilford Pharmaceuticals Inc
|
United States |
|
N/A
|
|
|
|
Icagen Inc
Biopharmaceutical company developing small molecule therapeutics that target ion channels for treatment of a variety of diseases. |
United States |
|
N/A
|
|
|
|
ILEX Oncology Inc
|
United States |
|
N/A
|
|
|
|
Immune Design Corp
|
United States |
|
N/A
|
|
|
|
Innate Pharma SA
|
France |
|
N/A
|
|
|
|
Insulet Corp
|
United States |
|
N/A
|
|
|
Intarcia Therapeutics Inc
A biopharmaceutical company applying a targeted approach to the acquisition, development and commercialization of novel therapeutic products for the t |
United States |
|
N/A
|
|
|
|
InterMune Inc
Biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and orphan fibrotic diseases. |
United States |
|
N/A
|
|
|
|
Intradigm Corp
|
United States |
1 Jan 2009 |
Series B
|
|
|
|
Intradigm Corp
|
United States |
1 Nov 2006 |
Series A
|
|
|
|
IRX Therapeutics Inc
|
United States |
|
N/A
|
|